2018 Annual Meeting | PL10 - Invited Science: Movement Disorders
| 01:00 PM - 01:20 PM | Speaker |
Tissue Engineered Nigrostriatal Pathway for Treatment of Parkinson's Disease
John E. Duda, MD |
| 01:20 PM - 01:40 PM | Speaker |
Which Clinical Features Predict Progressive Supranuclear Palsy Pathology? A Clinicopathological Study on 437 Autopsy Cases and A Literature Review
Gesine Respondek, MD |
| 01:40 PM - 02:00 PM | Speaker |
Skin Nerve Phosphorylated a-synuclein Deposits in Idiopathic REM Sleep Behavior Disorder
Elena Antelmi, MD |
| 02:00 PM - 02:20 PM | Speaker |
Results From A Phase 1b Multiple Ascending-dose Study of prx002, An Anti–alpha-synuclein Monoclonal Antibody, in Patients with Parkinson's Disease
Joseph Jankovic, MD, FAAN |
| 02:20 PM - 02:40 PM | Speaker |
The Effect of Early STN-DBS in PD Patients on Axial Symptoms: a 2-year Randomized Controlled Trial (EARLYSTIM-Gait Analysis)
Michael Barbe |
| 02:40 PM - 03:00 PM | Speaker |
Exercise Alters Response of Reward Anticipation in the Ventral Striatum of Subjects with Parkinson's Disease
Matthew Sacheli |
| Joseph Jankovic, MD, FAAN | Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie. |
| Michael Barbe | No disclosure on file |
| John E. Duda, MD | Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health. |
| Matthew Sacheli | No disclosure on file |
| Gesine Respondek, MD | Gesine Respondek, MD has received personal compensation for serving as an employee of Hoffmann-La Roche. Gesine Respondek, MD has stock in Hoffmann-La Roche. |
| Elena Antelmi, MD | No disclosure on file |
| A J. Stoessl, MD, FAAN | No disclosure on file |
| Cynthia L. Comella, MD, FAAN | Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care. |